One Step Vending Corp. (KOSK)
USD 0.02
(3.88%)
USD 0.02
(3.88%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -27.79 Thousand USD | -26.28% |
| 2022 | -22 Thousand USD | 71.71% |
| 2021 | -77.79 Thousand USD | -45.9% |
| 2020 | -53.31 Thousand USD | -513.54% |
| 2019 | -8690.00 USD | 99.17% |
| 2018 | -1.04 Million USD | -46694.95% |
| 2017 | -2236.00 USD | 0.0% |
| 2015 | -129.17 Thousand USD | 41.18% |
| 2014 | -219.59 Thousand USD | -47449.66% |
| 2013 | -461.81 USD | 0.0% |
| 2009 | -95.13 Thousand USD | 44.27% |
| 2008 | -170.72 Thousand USD | 82.83% |
| 2007 | -994.58 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -2454.00 USD | 53.45% |
| 2024 Q1 | -5272.00 USD | 62.24% |
| 2023 Q2 | -3326.00 USD | -22.78% |
| 2023 Q1 | -2709.00 USD | 63.67% |
| 2023 Q4 | -13.96 Thousand USD | -174.55% |
| 2023 FY | -27.79 Thousand USD | -26.28% |
| 2023 Q3 | -5085.00 USD | -52.89% |
| 2022 FY | -22 Thousand USD | 71.71% |
| 2022 Q2 | -8167.00 USD | -65.83% |
| 2022 Q3 | -1458.00 USD | 82.15% |
| 2022 Q4 | -7457.00 USD | -411.45% |
| 2022 Q1 | -4925.00 USD | 20.22% |
| 2021 Q3 | -3794.00 USD | 25.31% |
| 2021 Q4 | -6173.00 USD | -62.7% |
| 2021 Q1 | -62.74 Thousand USD | 0.0% |
| 2021 FY | -77.79 Thousand USD | -45.9% |
| 2021 Q2 | -5080.00 USD | 91.9% |
| 2020 FY | -53.31 Thousand USD | -513.54% |
| 2019 FY | -8690.00 USD | 99.17% |
| 2018 FY | -1.04 Million USD | -46694.95% |
| 2017 FY | -2236.00 USD | 0.0% |
| 2015 FY | -129.17 Thousand USD | 41.18% |
| 2014 Q2 | -65.64 USD | -0.84% |
| 2014 FY | -219.59 Thousand USD | -47449.66% |
| 2014 Q3 | -49.73 USD | 24.24% |
| 2014 Q1 | -65.09 USD | 69.81% |
| 2014 Q4 | -38.97 USD | 21.63% |
| 2013 Q3 | -73.75 USD | 19.56% |
| 2013 FY | -461.81 USD | 0.0% |
| 2013 Q4 | -215.58 USD | -192.32% |
| 2013 Q2 | -91.68 USD | -15.73% |
| 2013 Q1 | -79.22 USD | 0.0% |
| 2010 Q3 | -70.48 Thousand USD | 29.94% |
| 2010 Q1 | -96.22 Thousand USD | -10.91% |
| 2010 Q2 | -100.59 Thousand USD | -4.54% |
| 2009 FY | -95.13 Thousand USD | 44.27% |
| 2009 Q4 | -86.76 Thousand USD | -3017.5% |
| 2009 Q1 | -5943.00 USD | 0.0% |
| 2009 Q3 | -2783.00 USD | -892.88% |
| 2009 Q2 | 351.00 USD | 105.91% |
| 2008 FY | -170.72 Thousand USD | 82.83% |
| 2007 Q1 | -344.11 Thousand USD | 0.0% |
| 2007 Q2 | -410.69 Thousand USD | -19.35% |
| 2007 FY | -994.58 Thousand USD | 0.0% |
| 2006 Q2 | -440.41 Thousand USD | -32.83% |
| 2006 Q1 | -331.57 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| China Medicine Corporation | 1.71 Million USD | 101.618% |
| DH Enchantment Inc. | -156.15 Thousand USD | 82.203% |
| Exlites Holdings International, Inc. | -90.49 Thousand USD | 69.29% |
| Itonis, Inc. | -38.31 Thousand USD | 27.466% |
| MediPal Holdings Corporation | 274.02 Million USD | 100.01% |
| PD-Rx Pharmaceuticals, Inc. | -98.06 Thousand USD | 71.661% |
| Pharmagen, Inc. | -6457.61 USD | -330.345% |
| Suzuken Co., Ltd. | 191.71 Billion USD | 100.0% |